Adjuvant Inhaled Corticosteroids in Community-Acquired Pneumonia: A Review Article
Community-acquired pneumonia is still a major cause of morbidity and mortality worldwide. Since the inflammatory response induced by the immune system is often a major contributor to the lung injury, it becomes reasonable to assess the potential benefit of anti-inflammatory agents in treating commun...
Main Authors: | Faeq R. Kukhon, Emir Festic |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Medical Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3271/9/2/34 |
Similar Items
-
Pre-hospital use of inhaled corticosteroids and inhaled beta agonists and incidence of ARDS: A population-based study
by: Asif Muhammad Mangi, et al.
Published: (2015-11-01) -
EARLY PRESCRIPTION OF INHALATION CORTICOSTEROID IN BRONCHIAL ASTHMA
by: Z. R. Aisanov, et al.
Published: (2017-11-01) -
Differences in health care outcomes between postdischarge COPD patients treated with inhaled corticosteroid/long-acting β2-agonist via dry-powder inhalers and pressurized metered-dose inhalers
by: Wittbrodt ET, et al.
Published: (2018-12-01) -
Real-Life Patterns of Exacerbations While on Inhaled Corticosteroids and Long-Acting Beta Agonists for Asthma over 15 Years
by: Michael J. McGeachie, et al.
Published: (2020-03-01) -
Inhalation of Budesonide/Formoterol Increases Diaphragm Muscle Contractility
by: Chiyohiko Shindoh, et al.
Published: (2012-01-01)